Federal PFAS Research Evaluation Act

Bill: 117-hr-7289
Sponsor: full_name: Rep. Fletcher, Lizzie [D-TX-7]
Introduced: 2022-03-30
Policy area: Environmental Protection
Subjects: Animal and plant health

Congressional oversight

Environmental assessment, monitoring, research

Environmental health

Government information and archives

Government studies and investigations

Hazardous wastes and toxic substances

Product safety and quality

Research administration and funding

Research and development
Latest action: action_date: 2022-07-27
text: Received in the Senate and Read twice and referred to the Committee on Environment and Public Works.

Summaries:
action_date: 2022-03-30
action_desc: Introduced in House
text: <p><b>Federal PFAS Research Evaluation Act</b></p> <p>This bill requires various studies and reports on the exposure, hazards, and management of perfluoroalkyl and polyfluoroalkyl substances, commonly referred to as PFAS. These substances are man-made and may have adverse human health effects. A variety of products contain the compounds, such as nonstick cookware or weatherproof clothing.</p> <p>Specifically, the bill requires the Environmental Protection Agency (EPA) to enter into an agreement with the National Academies of Sciences, Engineering, and Medicine (NASEM) to conduct a two-phase study and report on the research and development needed to advance human exposure estimation and toxicity hazard estimation of individual or total PFAS.</p> <p>The bill also requires the EPA to jointly enter into an agreement with NASEM to conduct a study and submit a report on the research and development needed to advance the understanding of the extent and implications of environmental contamination by PFAS, how to manage and treat such contamination, and the development of safe alternatives.</p> <p>Finally, the White House Office of Science and Technology Policy must submit an implementation plan for federal PFAS research, development, and demonstration activities, taking into account the recommendations of the NASEM reports.</p>

action_date: 2022-07-13
action_desc: Reported to House
text: <p><strong>Federal PFAS Research Evaluation Act</strong></p> <p>This bill requires the Environmental Protection Agency (EPA) to enter into an agreement with the National Academies of Sciences, Engineering, and Medicine (NASEM) to complete various studies and reports related to perfluoroalkyl and polyfluoroalkyl substances, commonly referred to as PFAS. PFAS are man-made and may have adverse human health effects. A variety of products contain the compounds, such as nonstick cookware or weatherproof clothing.</p> <p>Specifically, the bill requires the EPA to enter into an agreement with NASEM to (1) study and report on research and knowledge gaps identified by the Federal Government Human Health PFAS Research Workshop (October 26 and 27, 2020); and (2) identify research and development needed to identify, categorize, evaluate, and address individual or total PFAS. Additionally, the EPA and other relevant federal agencies must enter into an agreement with NASEM to submit a study and report to better understand the research and development needed to better understand the extent and implications of human and environmental contamination by PFAS and any management and treatment options.</p> <p>After NASEM submits the required reports, the White House Office of Science and Technology Policy must submit an implementation plan to Congress for increased collaboration and coordination of federal PFAS research, development, and demonstration activities.</p>

action_date: 2022-07-26
action_desc: Passed House
text: <p><strong>Federal PFAS Research Evaluation Act</strong></p> <p>This bill requires the Environmental Protection Agency (EPA) to enter into an agreement with the National Academies of Sciences, Engineering, and Medicine (NASEM) to complete various studies and reports related to perfluoroalkyl and polyfluoroalkyl substances, commonly referred to as PFAS. PFAS are man-made and may have adverse human health effects. A variety of products contain the compounds, such as nonstick cookware or weatherproof clothing.</p> <p>Specifically, the bill requires the EPA to enter into an agreement with NASEM to (1) study and report on research and knowledge gaps identified by the Federal Government Human Health PFAS Research Workshop (October 26 and 27, 2020); and (2) identify research and development needed to identify, categorize, evaluate, and address individual or total PFAS. Additionally, the EPA and other relevant federal agencies must enter into an agreement with NASEM to submit a study and report to better understand the research and development needed to better understand the extent and implications of human and environmental contamination by PFAS and any management and treatment options.</p> <p>After NASEM submits the required reports, the White House Office of Science and Technology Policy must submit an implementation plan to Congress for increased collaboration and coordination of federal PFAS research, development, and demonstration activities.</p>

tv_txt: I 117th CONGRESS 2d Session H. R. 7289 IN THE HOUSE OF REPRESENTATIVES March 30, 2022 Mrs. Fletcher (for herself and Mr. Meijer ) introduced the following bill; which was referred to the Committee on Science, Space, and Technology A BILL To provide for the National Academies to study and report on a Federal research agenda to advance the understanding of PFAS, and for other purposes.

1. Short title This Act may be cited as the Federal PFAS Research Evaluation Act . 2. Findings Congress finds the following: (1) Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are a group of man-made chemicals that have been used in a wide range of products since the 1940s including firefighting foam, carpeting, packaging, and cookware. There are more than 5,000 types of registered PFAS compounds. This chemical class is not currently regulated at the Federal level. (2) PFAS have been detected in air, water, soil, food, biosolids, and more. They accumulate and remain in the body for a long time, and can lead to serious health effects including cancer, low infant birthweight, liver and kidney issues, reproductive and developmental problems, and more. (3) There remains much unknown about PFAS toxicity, human and environmental health effects, exposure pathways, as well as effective removal, treatment, and destruction methods, and safe alternatives to PFAS. (4) There is currently no cohesive, interagency effort to address PFAS, and no Federal agency is focused on a multidisciplinary, cross-sector approach. Rather, there are fragmented efforts at various agencies that have failed to address the full scope of challenges presented by PFAS. (5) Regulatory action and cleanup depend on scientific analysis of toxicity data, decision making on how best to deal with the thousands of PFAS, and understanding the significance of the many exposure pathways that exist. A consensus study by the National Academies of Sciences, Engineering, and Medicine would help inform decisions by Federal and State Governments, industry, and other stakeholders on how to best address PFAS. 3. National Academies reports (a) Research assessments of PFAS exposure and toxicity (1) In General Not later than 90 days after the date of enactment of this Act, the Administrator of the Environmental Protection Agency, in consultation with the Director of the National Science Foundation, the Secretary of Defense, the Director of the National Institutes of Health, and other Federal agencies with expertise relevant to understanding PFAS exposure and toxicity, shall enter into an agreement with the National Academies to conduct a two-phase study and submit reports in accordance with this subsection to identify research and development needed to advance human exposure estimation and toxicity and hazard estimation of individual or total PFAS. (2) Phase I study and report on human exposure estimation (A) In general The phase I study required to be conducted under paragraph (1) shall, at a minimum— (i) consider life-cycle information on the manufacture, use, and disposal of PFAS-containing products to identify exposure sources and potential exposure pathways for the public; (ii) evaluate the fate and transport of PFAS and their breakdown products; (iii) if feasible, estimate exposure to individual or total PFAS to determine relative source contributions for various exposure pathways (such as air, water, soil, or food); (iv) determine environmentally relevant PFAS; and (v) identify research needed to advance exposure estimation to individual or total PFAS. (B) Report Not later than 270 days after the date on which the agreement described in paragraph (1) is finalized, the National Academies shall submit to Congress a report containing the findings and recommendations of the study described in subparagraph (A) and shall make such report available on a publicly accessible website. (3) Phase II study and report on PFAS toxicity and hazard estimation (A) In general The phase II study required to be conducted under paragraph (1) shall, at a minimum— (i) review animal and human toxicity information on the environmentally relevant PFAS identified in the Phase I report under paragraph (2) and develop an approach for conducting a hazard assessment of these PFAS; (ii) give consideration as to whether chemical category-based approaches for assessing toxicity would be appropriate for evaluating PFAS as a group; and (iii) identify research needed to advance toxicity and hazard assessment of individual or total PFAS. (B) Report Not later than 270 days after the date on which the Phase I report is submitted to Congress under paragraph (2), the National Academies shall submit to Congress a report containing the findings and recommendations of the study described in subparagraph (A) and shall make such report available on a publicly accessible website. (b) Research assessment of management and treatment alternatives for PFAS contamination in the environment (1) In General Not later than 90 days after the date of enactment of this Act, the Administrator of the Environmental Protection Agency and the Director of the National Science Foundation, in consultation with the Secretary of Defense and other Federal agencies with expertise relevant to the development of PFAS alternatives and the management and treatment of PFAS, shall jointly enter into an agreement with the National Academies to conduct a study and submit a report in accordance with this subsection to better understand the research and development needed to advance the understanding of the extent and implications of environmental contamination by PFAS, how to manage and treat such contamination, and the development of safe alternatives. (2) Scope of study The study described in paragraph (1) shall, at a minimum, include the following: (A) An assessment of the current research on such issues. (B) A description of the research gaps relating to such issues. (C) Recommendations on how the Federal Government can address the research needs identified pursuant to subparagraph (B). (D) Recommendations on how research can best incorporate considerations of socioeconomic issues into the development of research proposals and the conduct of research. (3) Report Not later than 540 days after the date on which the agreement described in paragraph (1) is finalized, the National Academies shall submit to Congress a report containing the findings and recommendations of the study described in paragraph (2) and shall make such report available on a publicly accessible website. (c) Authorization of Appropriations There is authorized to be appropriated to carry out this section— (1) to the Administrator of Environmental Protection Agency, $3,000,000; and (2) to the Director of the National Science Foundation, $1,000,000. 4. Implementation plan Not later than 180 days after submission to Congress of latest of the National Academies reports under section 3, the Director of the Office of Science and Technology Policy, in coordination with all relevant Federal agencies, shall submit to Congress an implementation plan for Federal PFAS research, development, and demonstration activities. In preparing such an implementation plan, the Director shall take into consideration the recommendations included in the reports in section 3. 5. Definitions In this Act: (1) National Academies The term National Academies means the National Academies of Sciences, Engineering, and Medicine. (2) PFAS The term PFAS means per- and polyfluoroalkyl substances.

tv_txt: I 117th CONGRESS 2d Session H. R. 7289 IN THE HOUSE OF REPRESENTATIVES AN ACT To provide for the National Academies to study and report on a Federal research agenda to advance the understanding of PFAS, and for other purposes.

1. Short title This Act may be cited as the Federal PFAS Research Evaluation Act . 2. Findings Congress finds the following: (1) Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are a group of man-made chemicals that have been used in a wide range of products since the 1940s including firefighting foam, carpeting, packaging, and cookware. There are more than 5,000 types of registered PFAS compounds. This chemical class is not currently regulated at the Federal level. (2) PFAS have been detected in air, water, soil, food, biosolids, and more. They can accumulate and remain in the body for a long time, and potentially lead to serious health effects including cancer, low infant birthweight, liver and kidney issues, reproductive and developmental problems, and more. (3) There remains much unknown about PFAS toxicity, human and environmental health effects, exposure pathways, as well as effective removal, treatment, and destruction methods, and safe alternatives to PFAS. (4) Federal research efforts have been fragmented at various agencies and struggled to effectively address the full scope of challenges presented by PFAS. (5) Regulatory action and cleanup depend on scientific analysis of toxicity data, decision making on how best to deal with PFAS, and understanding the significance of the many exposure pathways that exist. A consensus study by the National Academies would help inform decisions by Federal and State Governments, industry, and other stakeholders on how to best address PFAS. 3. National Academies reports (a) Research assessments of PFAS (1) In general Not later than 90 days after the date on which amounts are appropriated for fiscal year 2023 to carry out this section, the Administrator of the Environmental Protection Agency, in consultation with the Director of the National Science Foundation, the Secretary of Defense, the Director of the National Institutes of Health, and other Federal agencies with expertise relevant to understanding PFAS exposure, behavior, and toxicity, shall enter into an agreement with the National Academies to conduct a study and submit a report in accordance with this subsection to further address research and knowledge gaps identified by the Federal Government Human Health PFAS Research Workshop held on October 26 and 27, 2020, and identify research and development needed to identify, categorize, evaluate, and address individual or total PFAS. (2) Study and report on human exposure estimation (A) In general The study required to be conducted under paragraph (1) shall, at a minimum— (i) consider life-cycle information on the manufacture, use, and disposal of PFAS-containing products to identify potential human exposure sources, including occupational exposures, and potential exposure pathways for the public; (ii) evaluate the fate and transport of PFAS and their breakdown products; (iii) if feasible, estimate human exposure to individual or total PFAS to determine relative source contributions for various exposure pathways (such as air, water, soil, or food); (iv) determine the range of solubility, stability, and volatility of PFAS most likely to be found in the environment and the resulting prevalence in animals and humans; (v) give consideration as to whether chemical category-based approaches would be appropriate for evaluating PFAS toxicity and exposure; (vi) identify research needed to advance exposure estimation to individual or total PFAS; and (vii) identify research needed to advance toxicity and hazard assessment of individual or total PFAS. (B) Report Not later than 540 days after the date on which the agreement described in paragraph (1) is finalized, the National Academies shall submit to Congress a report containing the findings and recommendations of the study described in subparagraph (A) and shall make such report available on a publicly accessible website. (b) Research assessment of management and treatment alternatives for PFAS contamination in the environment (1) In general Not later than 90 days after the date on which amounts are appropriated for fiscal year 2023 to carry out this section, the Administrator of the Environmental Protection Agency and the Director of the National Science Foundation, in consultation with the Secretary of Defense and other Federal agencies with expertise relevant to the development of PFAS alternatives and the management and treatment of PFAS, shall jointly enter into an agreement with the National Academies to conduct a study and submit a report in accordance with this subsection to better understand the research and development needed to advance the understanding of the extent and implications of human and environmental contamination by PFAS, how to manage and treat such contamination, and the development of safe alternatives. (2) Scope of study The study described in paragraph (1) shall, at a minimum, include the following: (A) An assessment of the best available strategies for PFAS treatment, site remediation, and safe disposal, including demonstration or pilot projects related to destruction methods and alternative materials or tools for firefighters. (B) A description of the research gaps relating to such issues, including consideration of emerging or future PFAS and potential classification methods. (C) Recommendations on how the Federal Government can best address the research needs identified pursuant to subparagraph (B) through increased collaboration or coordination of existing and new programs. (D) Recommendations on how research can best incorporate considerations of socioeconomic issues into the development of research proposals and the conduct of research. (3) Report Not later than 540 days after the date on which the agreement described in paragraph (1) is finalized, the National Academies shall submit to Congress a report containing the findings and recommendations of the study described in paragraph (2) and shall make such report available on a publicly accessible website. (c) Authorization of appropriations There is authorized to be appropriated for fiscal year 2023 $3,000,000 to the Administrator of the Environmental Protection Agency to carry out this section. 4. Implementation plan Not later than 180 days after submission to Congress of latest of the National Academies reports under section 3, the Director of the Office of Science and Technology Policy, in coordination with all relevant Federal agencies, shall submit to Congress an implementation plan for increased collaboration and coordination of Federal PFAS research, development, and demonstration activities. In preparing such an implementation plan, the Director shall take into consideration the recommendations included in the reports in section 3. 5. Definitions In this Act: (1) National Academies The term National Academies means the National Academies of Sciences, Engineering, and Medicine. (2) PFAS The term PFAS means per- and polyfluoroalkyl substances, including mixtures of such substances.

Passed the House of Representatives July 26, 2022. Cheryl L. Johnson, Clerk.

tv_txt: IIB 117th CONGRESS 2d Session H. R. 7289 IN THE SENATE OF THE UNITED STATES July 27, 2022 Received; read twice and referred to the Committee on Environment and Public Works AN ACT To provide for the National Academies to study and report on a Federal research agenda to advance the understanding of PFAS, and for other purposes.

1. Short title This Act may be cited as the Federal PFAS Research Evaluation Act . 2. Findings Congress finds the following: (1) Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are a group of man-made chemicals that have been used in a wide range of products since the 1940s including firefighting foam, carpeting, packaging, and cookware. There are more than 5,000 types of registered PFAS compounds. This chemical class is not currently regulated at the Federal level. (2) PFAS have been detected in air, water, soil, food, biosolids, and more. They can accumulate and remain in the body for a long time, and potentially lead to serious health effects including cancer, low infant birthweight, liver and kidney issues, reproductive and developmental problems, and more. (3) There remains much unknown about PFAS toxicity, human and environmental health effects, exposure pathways, as well as effective removal, treatment, and destruction methods, and safe alternatives to PFAS. (4) Federal research efforts have been fragmented at various agencies and struggled to effectively address the full scope of challenges presented by PFAS. (5) Regulatory action and cleanup depend on scientific analysis of toxicity data, decision making on how best to deal with PFAS, and understanding the significance of the many exposure pathways that exist. A consensus study by the National Academies would help inform decisions by Federal and State Governments, industry, and other stakeholders on how to best address PFAS. 3. National Academies reports (a) Research assessments of PFAS (1) In general Not later than 90 days after the date on which amounts are appropriated for fiscal year 2023 to carry out this section, the Administrator of the Environmental Protection Agency, in consultation with the Director of the National Science Foundation, the Secretary of Defense, the Director of the National Institutes of Health, and other Federal agencies with expertise relevant to understanding PFAS exposure, behavior, and toxicity, shall enter into an agreement with the National Academies to conduct a study and submit a report in accordance with this subsection to further address research and knowledge gaps identified by the Federal Government Human Health PFAS Research Workshop held on October 26 and 27, 2020, and identify research and development needed to identify, categorize, evaluate, and address individual or total PFAS. (2) Study and report on human exposure estimation (A) In general The study required to be conducted under paragraph (1) shall, at a minimum— (i) consider life-cycle information on the manufacture, use, and disposal of PFAS-containing products to identify potential human exposure sources, including occupational exposures, and potential exposure pathways for the public; (ii) evaluate the fate and transport of PFAS and their breakdown products; (iii) if feasible, estimate human exposure to individual or total PFAS to determine relative source contributions for various exposure pathways (such as air, water, soil, or food); (iv) determine the range of solubility, stability, and volatility of PFAS most likely to be found in the environment and the resulting prevalence in animals and humans; (v) give consideration as to whether chemical category-based approaches would be appropriate for evaluating PFAS toxicity and exposure; (vi) identify research needed to advance exposure estimation to individual or total PFAS; and (vii) identify research needed to advance toxicity and hazard assessment of individual or total PFAS. (B) Report Not later than 540 days after the date on which the agreement described in paragraph (1) is finalized, the National Academies shall submit to Congress a report containing the findings and recommendations of the study described in subparagraph (A) and shall make such report available on a publicly accessible website. (b) Research assessment of management and treatment alternatives for PFAS contamination in the environment (1) In general Not later than 90 days after the date on which amounts are appropriated for fiscal year 2023 to carry out this section, the Administrator of the Environmental Protection Agency and the Director of the National Science Foundation, in consultation with the Secretary of Defense and other Federal agencies with expertise relevant to the development of PFAS alternatives and the management and treatment of PFAS, shall jointly enter into an agreement with the National Academies to conduct a study and submit a report in accordance with this subsection to better understand the research and development needed to advance the understanding of the extent and implications of human and environmental contamination by PFAS, how to manage and treat such contamination, and the development of safe alternatives. (2) Scope of study The study described in paragraph (1) shall, at a minimum, include the following: (A) An assessment of the best available strategies for PFAS treatment, site remediation, and safe disposal, including demonstration or pilot projects related to destruction methods and alternative materials or tools for firefighters. (B) A description of the research gaps relating to such issues, including consideration of emerging or future PFAS and potential classification methods. (C) Recommendations on how the Federal Government can best address the research needs identified pursuant to subparagraph (B) through increased collaboration or coordination of existing and new programs. (D) Recommendations on how research can best incorporate considerations of socioeconomic issues into the development of research proposals and the conduct of research. (3) Report Not later than 540 days after the date on which the agreement described in paragraph (1) is finalized, the National Academies shall submit to Congress a report containing the findings and recommendations of the study described in paragraph (2) and shall make such report available on a publicly accessible website. (c) Authorization of appropriations There is authorized to be appropriated for fiscal year 2023 $3,000,000 to the Administrator of the Environmental Protection Agency to carry out this section. 4. Implementation plan Not later than 180 days after submission to Congress of latest of the National Academies reports under section 3, the Director of the Office of Science and Technology Policy, in coordination with all relevant Federal agencies, shall submit to Congress an implementation plan for increased collaboration and coordination of Federal PFAS research, development, and demonstration activities. In preparing such an implementation plan, the Director shall take into consideration the recommendations included in the reports in section 3. 5. Definitions In this Act: (1) National Academies The term National Academies means the National Academies of Sciences, Engineering, and Medicine. (2) PFAS The term PFAS means per- and polyfluoroalkyl substances, including mixtures of such substances.

Passed the House of Representatives July 26, 2022. Cheryl L. Johnson, Clerk.

tv_txt: IB Union Calendar No. 313 117th CONGRESS 2d Session H. R. 7289 [Report No. 117–406] IN THE HOUSE OF REPRESENTATIVES March 30, 2022 Mrs. Fletcher (for herself and Mr. Meijer ) introduced the following bill; which was referred to the Committee on Science, Space, and Technology July 13, 2022 Additional sponsors: Ms. Bonamici , Mr. Posey , Ms. Stevens , Mr. Kildee , Mr. Fitzpatrick , and Mr. Gallagher July 13, 2022 Reported with an amendment, committed to the Committee of the Whole House on the State of the Union, and ordered to be printed Strike out all after the enacting clause and insert the part printed in italic For text of introduced bill, see copy of bill as introduced on March 30, 2022 A BILL To provide for the National Academies to study and report on a Federal research agenda to advance the understanding of PFAS, and for other purposes.

1. Short title This Act may be cited as the Federal PFAS Research Evaluation Act . 2. Findings Congress finds the following: (1) Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are a group of man-made chemicals that have been used in a wide range of products since the 1940s including firefighting foam, carpeting, packaging, and cookware. There are more than 5,000 types of registered PFAS compounds. This chemical class is not currently regulated at the Federal level. (2) PFAS have been detected in air, water, soil, food, biosolids, and more. They can accumulate and remain in the body for a long time, and potentially lead to serious health effects including cancer, low infant birthweight, liver and kidney issues, reproductive and developmental problems, and more. (3) There remains much unknown about PFAS toxicity, human and environmental health effects, exposure pathways, as well as effective removal, treatment, and destruction methods, and safe alternatives to PFAS. (4) Federal research efforts have been fragmented at various agencies and struggled to effectively address the full scope of challenges presented by PFAS. (5) Regulatory action and cleanup depend on scientific analysis of toxicity data, decision making on how best to deal with PFAS, and understanding the significance of the many exposure pathways that exist. A consensus study by the National Academies of Sciences, Engineering, and Medicine would help inform decisions by Federal and State Governments, industry, and other stakeholders on how to best address PFAS. 3. National Academies reports (a) Research assessments of PFAS (1) In general Not later than 90 days after the date of enactment of this Act, the Administrator of the Environmental Protection Agency, in consultation with the Director of the National Science Foundation, the Secretary of Defense, the Director of the National Institutes of Health, and other Federal agencies with expertise relevant to understanding PFAS exposure, behavior, and toxicity, shall enter into an agreement with the National Academies to conduct a study and submit a report in accordance with this subsection to further address research and knowledge gaps identified by the Federal Government Human Health PFAS Research Workshop held on October 26 and 27, 2020, and identify research and development needed to identify, categorize, evaluate, and address individual or total PFAS. (2) Study and report on human exposure estimation (A) In general The study required to be conducted under paragraph (1) shall, at a minimum— (i) consider life-cycle information on the manufacture, use, and disposal of PFAS-containing products to identify potential human exposure sources, including occupational exposures, and potential exposure pathways for the public; (ii) evaluate the fate and transport of PFAS and their breakdown products; (iii) if feasible, estimate human exposure to individual or total PFAS to determine relative source contributions for various exposure pathways (such as air, water, soil, or food); (iv) determine the range of solubility, stability, and volatility of PFAS most likely to be found in the environment and the resulting prevalence in animals and humans; (v) give consideration as to whether chemical category-based approaches would be appropriate for evaluating PFAS toxicity and exposure; (vi) identify research needed to advance exposure estimation to individual or total PFAS; and (vii) identify research needed to advance toxicity and hazard assessment of individual or total PFAS. (B) Report Not later than 540 days after the date on which the agreement described in paragraph (1) is finalized, the National Academies shall submit to Congress a report containing the findings and recommendations of the study described in subparagraph (A) and shall make such report available on a publicly accessible website. (b) Research assessment of management and treatment alternatives for PFAS contamination in the environment (1) In general Not later than 90 days after the date of enactment of this Act, the Administrator of the Environmental Protection Agency and the Director of the National Science Foundation, in consultation with the Secretary of Defense and other Federal agencies with expertise relevant to the development of PFAS alternatives and the management and treatment of PFAS, shall jointly enter into an agreement with the National Academies to conduct a study and submit a report in accordance with this subsection to better understand the research and development needed to advance the understanding of the extent and implications of human and environmental contamination by PFAS, how to manage and treat such contamination, and the development of safe alternatives. (2) Scope of study The study described in paragraph (1) shall, at a minimum, include the following: (A) An assessment of the best available strategies for PFAS treatment, site remediation, and safe disposal, including demonstration or pilot projects related to destruction methods and alternative materials or tools for firefighters. (B) A description of the research gaps relating to such issues, including consideration of emerging or future PFAS and potential classification methods. (C) Recommendations on how the Federal Government can best address the research needs identified pursuant to subparagraph (B) through increased collaboration or coordination of existing and new programs. (D) Recommendations on how research can best incorporate considerations of socioeconomic issues into the development of research proposals and the conduct of research. (3) Report Not later than 540 days after the date on which the agreement described in paragraph (1) is finalized, the National Academies shall submit to Congress a report containing the findings and recommendations of the study described in paragraph (2) and shall make such report available on a publicly accessible website. (c) Authorization of appropriations There is authorized to be appropriated $3,000,000 to the Administrator of the Environmental Protection Agency to carry out this section. 4. Implementation plan Not later than 180 days after submission to Congress of latest of the National Academies reports under section 3, the Director of the Office of Science and Technology Policy, in coordination with all relevant Federal agencies, shall submit to Congress an implementation plan for increased collaboration and coordination of Federal PFAS research, development, and demonstration activities. In preparing such an implementation plan, the Director shall take into consideration the recommendations included in the reports in section 3. 5. Definitions In this Act: (1) National Academies The term National Academies means the National Academies of Sciences, Engineering, and Medicine. (2) PFAS The term PFAS means per- and polyfluoroalkyl substances, including mixtures of such substances.

July 13, 2022 Reported with an amendment, committed to the Committee of the Whole House on the State of the Union, and ordered to be printed